{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:59:41Z","timestamp":1780775981262,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007673","name":"Fondation Centre de Recherches M\u00e9dicales Carlos et Elsie de Reuter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijcha.2026.101909","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:09:24Z","timestamp":1774325364000},"page":"101909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Low-dose ventricular radiotherapy in wild-type transthyretin cardiac amyloidosis: a prospective, first-in-human, exploratory clinical trial"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-9831","authenticated-orcid":false,"given":"Damien","family":"Guijarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Nkoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcha.2026.101909_b0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101909_b0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101909_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101909_b0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.125.077304","article-title":"Coramitug, a humanized monoclonal antibody for the treatment of transthyretin amyloid cardiomyopathy: a phase 2, randomized, multicenter, double-blind, placebo-controlled trial","volume":"153","author":"Fontana","year":"2026","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcha.2026.101909_b0030","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.114.5.1489","article-title":"Radiation therapy for tracheobronchial amyloidosis","volume":"114","author":"Kurrus","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijcha.2026.101909_b0035","first-page":"42","article-title":"Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modality","volume":"10","author":"Poovaneswaran","year":"2008","journal-title":"Medscape J. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.06-3118","article-title":"External beam radiation therapy for tracheobronchial amyloidosis","volume":"132","author":"Neben-Wittich","year":"2007","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijcha.2026.101909_b0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10103-016-1917-8","article-title":"Treatment of primary cutaneous amyloidosis with laser: a review of the literature","volume":"31","author":"Al Yahya","year":"2016","journal-title":"Lasers Med. Sci."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101909_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/01676830.2018.1483407","article-title":"External beam radiation for localized periocular amyloidosis: a case series","volume":"38","author":"Copperman","year":"2019","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.ijcha.2026.101909_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/01676830802350216","article-title":"The use of radiotherapy for the treatment of localized orbital amyloidosis","volume":"27","author":"Khaira","year":"2008","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.prro.2017.08.003","article-title":"External beam radiation therapy for amyloidosis of the urinary bladder","volume":"8","author":"Cooper","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101909_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-190984","article-title":"Low-dose radiation therapy: a new treatment strategy for Alzheimer\u2019s disease?","volume":"74","author":"Ceyz\u00e9riat","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2023.11.044","article-title":"Radiation therapy in Alzheimer\u2019s disease: a systematic review","volume":"119","author":"Kaul","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506129.2023.2263620","article-title":"Heterogeneous worldwide access and pricing of Tafamidis","volume":"31","author":"Wardhere","year":"2024","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2015.10.019","article-title":"Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer\u2019s disease (AD)","volume":"118","author":"Marples","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"9","key":"10.1016\/j.ijcha.2026.101909_b0085","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"24","key":"10.1016\/j.ijcha.2026.101909_b0090","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","article-title":"Noninvasive cardiac radiation for ablation of ventricular tachycardia","volume":"377","author":"Cuculich","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101909_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jrr\/rrae090","article-title":"Stereotactic arrhythmia radioablation for ventricular tachycardia: a review of clinical trials and emerging roles of imaging","volume":"66","author":"Kawamura","year":"2025","journal-title":"J. Radiat. Res."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101909_b0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann. Nucl. Med."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:22:59Z","timestamp":1780773779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S2352906726000436"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101909","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose ventricular radiotherapy in wild-type transthyretin cardiac amyloidosis: a prospective, first-in-human, exploratory clinical trial","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101909"}}